Range modulation in proton therapy planning: A simple method for mitigating effects of increased relative biological effectiveness at the end-of-range of clinical proton beams

Jeffrey C. Buchsbaum, Mark W. McDonald, Peter A S Johnstone, Ted Hoene, Marc Mendonca, Chee Wei Cheng, Indra J. Das, Kevin P. McMullen, Mark R. Wolanski

Research output: Contribution to journalArticle

15 Citations (Scopus)

Abstract

Background: The increase in relative biological effectiveness (RBE) of proton beams at the distal edge of the spread out Bragg peak (SOBP) is a well-known phenomenon that is difficult to quantify accurately in vivo. For purposes of treatment planning, disallowing the distal SOBP to fall within vulnerable tissues hampers sparing to the extent possible with proton beam therapy (PBT). We propose the distal RBE uncertainty may be straightforwardly mitigated with a technique we call " range modulation" With range modulation, the distal falloff is smeared, reducing both the dose and average RBE over the terminal few millimeters of the SOBP.Methods: One patient plan was selected to serve as an example for direct comparison of image-guided radiotherapy plans using non-range modulation PBT (NRMPBT), and range-modulation PBT (RMPBT). An additional plan using RMPBT was created to represent a re-treatment scenario (RMPBTrt) using a vertex beam. Planning statistics regarding dose, volume of the planning targets, and color images of the plans are shown.Results: The three plans generated for this patient reveal that in all cases dosimetric and device manufacturing advantages are able to be achieved using RMPBT. Organ at risk (OAR) doses to critical structures such as the cochleae, optic apparatus, hypothalamus, and temporal lobes can be selectively spared using this method. Concerns about the location of the RBE that did significantly impact beam selection and treatment planning no longer have the same impact on the process, allowing these structures to be spared dose and subsequent associated issues.Conclusions: This present study has illustrated that RMPBT can improve OAR sparing while giving equivalent coverage to target volumes relative to traditional PBT methods while avoiding the increased RBE at the end of the beam. It has proven easy to design and implement and robust in our planning process. The method underscores the need to optimize treatment plans in PBT for both traditional energy dose in gray (Gy) and biologic dose (RBE).

Original languageEnglish
Article number2
JournalRadiation Oncology
Volume9
Issue number1
DOIs
StatePublished - Jan 2 2014

Fingerprint

Relative Biological Effectiveness
Proton Therapy
Protons
Organs at Risk
Image-Guided Radiotherapy
Cochlea
Temporal Lobe
Therapeutics
Hypothalamus
Uncertainty
Color
Equipment and Supplies

Keywords

  • Bragg peak
  • Patient safety
  • Proton dosimetry
  • Proton therapy
  • Relative biological effectiveness (RBE)
  • Toxicity
  • Treatment planning

ASJC Scopus subject areas

  • Oncology
  • Radiology Nuclear Medicine and imaging

Cite this

Range modulation in proton therapy planning : A simple method for mitigating effects of increased relative biological effectiveness at the end-of-range of clinical proton beams. / Buchsbaum, Jeffrey C.; McDonald, Mark W.; Johnstone, Peter A S; Hoene, Ted; Mendonca, Marc; Cheng, Chee Wei; Das, Indra J.; McMullen, Kevin P.; Wolanski, Mark R.

In: Radiation Oncology, Vol. 9, No. 1, 2, 02.01.2014.

Research output: Contribution to journalArticle

Buchsbaum, Jeffrey C. ; McDonald, Mark W. ; Johnstone, Peter A S ; Hoene, Ted ; Mendonca, Marc ; Cheng, Chee Wei ; Das, Indra J. ; McMullen, Kevin P. ; Wolanski, Mark R. / Range modulation in proton therapy planning : A simple method for mitigating effects of increased relative biological effectiveness at the end-of-range of clinical proton beams. In: Radiation Oncology. 2014 ; Vol. 9, No. 1.
@article{625ac77e54104de288d83ec6f0d53ff7,
title = "Range modulation in proton therapy planning: A simple method for mitigating effects of increased relative biological effectiveness at the end-of-range of clinical proton beams",
abstract = "Background: The increase in relative biological effectiveness (RBE) of proton beams at the distal edge of the spread out Bragg peak (SOBP) is a well-known phenomenon that is difficult to quantify accurately in vivo. For purposes of treatment planning, disallowing the distal SOBP to fall within vulnerable tissues hampers sparing to the extent possible with proton beam therapy (PBT). We propose the distal RBE uncertainty may be straightforwardly mitigated with a technique we call {"} range modulation{"} With range modulation, the distal falloff is smeared, reducing both the dose and average RBE over the terminal few millimeters of the SOBP.Methods: One patient plan was selected to serve as an example for direct comparison of image-guided radiotherapy plans using non-range modulation PBT (NRMPBT), and range-modulation PBT (RMPBT). An additional plan using RMPBT was created to represent a re-treatment scenario (RMPBTrt) using a vertex beam. Planning statistics regarding dose, volume of the planning targets, and color images of the plans are shown.Results: The three plans generated for this patient reveal that in all cases dosimetric and device manufacturing advantages are able to be achieved using RMPBT. Organ at risk (OAR) doses to critical structures such as the cochleae, optic apparatus, hypothalamus, and temporal lobes can be selectively spared using this method. Concerns about the location of the RBE that did significantly impact beam selection and treatment planning no longer have the same impact on the process, allowing these structures to be spared dose and subsequent associated issues.Conclusions: This present study has illustrated that RMPBT can improve OAR sparing while giving equivalent coverage to target volumes relative to traditional PBT methods while avoiding the increased RBE at the end of the beam. It has proven easy to design and implement and robust in our planning process. The method underscores the need to optimize treatment plans in PBT for both traditional energy dose in gray (Gy) and biologic dose (RBE).",
keywords = "Bragg peak, Patient safety, Proton dosimetry, Proton therapy, Relative biological effectiveness (RBE), Toxicity, Treatment planning",
author = "Buchsbaum, {Jeffrey C.} and McDonald, {Mark W.} and Johnstone, {Peter A S} and Ted Hoene and Marc Mendonca and Cheng, {Chee Wei} and Das, {Indra J.} and McMullen, {Kevin P.} and Wolanski, {Mark R.}",
year = "2014",
month = "1",
day = "2",
doi = "10.1186/1748-717X-9-2",
language = "English",
volume = "9",
journal = "Radiation Oncology",
issn = "1748-717X",
publisher = "BioMed Central",
number = "1",

}

TY - JOUR

T1 - Range modulation in proton therapy planning

T2 - A simple method for mitigating effects of increased relative biological effectiveness at the end-of-range of clinical proton beams

AU - Buchsbaum, Jeffrey C.

AU - McDonald, Mark W.

AU - Johnstone, Peter A S

AU - Hoene, Ted

AU - Mendonca, Marc

AU - Cheng, Chee Wei

AU - Das, Indra J.

AU - McMullen, Kevin P.

AU - Wolanski, Mark R.

PY - 2014/1/2

Y1 - 2014/1/2

N2 - Background: The increase in relative biological effectiveness (RBE) of proton beams at the distal edge of the spread out Bragg peak (SOBP) is a well-known phenomenon that is difficult to quantify accurately in vivo. For purposes of treatment planning, disallowing the distal SOBP to fall within vulnerable tissues hampers sparing to the extent possible with proton beam therapy (PBT). We propose the distal RBE uncertainty may be straightforwardly mitigated with a technique we call " range modulation" With range modulation, the distal falloff is smeared, reducing both the dose and average RBE over the terminal few millimeters of the SOBP.Methods: One patient plan was selected to serve as an example for direct comparison of image-guided radiotherapy plans using non-range modulation PBT (NRMPBT), and range-modulation PBT (RMPBT). An additional plan using RMPBT was created to represent a re-treatment scenario (RMPBTrt) using a vertex beam. Planning statistics regarding dose, volume of the planning targets, and color images of the plans are shown.Results: The three plans generated for this patient reveal that in all cases dosimetric and device manufacturing advantages are able to be achieved using RMPBT. Organ at risk (OAR) doses to critical structures such as the cochleae, optic apparatus, hypothalamus, and temporal lobes can be selectively spared using this method. Concerns about the location of the RBE that did significantly impact beam selection and treatment planning no longer have the same impact on the process, allowing these structures to be spared dose and subsequent associated issues.Conclusions: This present study has illustrated that RMPBT can improve OAR sparing while giving equivalent coverage to target volumes relative to traditional PBT methods while avoiding the increased RBE at the end of the beam. It has proven easy to design and implement and robust in our planning process. The method underscores the need to optimize treatment plans in PBT for both traditional energy dose in gray (Gy) and biologic dose (RBE).

AB - Background: The increase in relative biological effectiveness (RBE) of proton beams at the distal edge of the spread out Bragg peak (SOBP) is a well-known phenomenon that is difficult to quantify accurately in vivo. For purposes of treatment planning, disallowing the distal SOBP to fall within vulnerable tissues hampers sparing to the extent possible with proton beam therapy (PBT). We propose the distal RBE uncertainty may be straightforwardly mitigated with a technique we call " range modulation" With range modulation, the distal falloff is smeared, reducing both the dose and average RBE over the terminal few millimeters of the SOBP.Methods: One patient plan was selected to serve as an example for direct comparison of image-guided radiotherapy plans using non-range modulation PBT (NRMPBT), and range-modulation PBT (RMPBT). An additional plan using RMPBT was created to represent a re-treatment scenario (RMPBTrt) using a vertex beam. Planning statistics regarding dose, volume of the planning targets, and color images of the plans are shown.Results: The three plans generated for this patient reveal that in all cases dosimetric and device manufacturing advantages are able to be achieved using RMPBT. Organ at risk (OAR) doses to critical structures such as the cochleae, optic apparatus, hypothalamus, and temporal lobes can be selectively spared using this method. Concerns about the location of the RBE that did significantly impact beam selection and treatment planning no longer have the same impact on the process, allowing these structures to be spared dose and subsequent associated issues.Conclusions: This present study has illustrated that RMPBT can improve OAR sparing while giving equivalent coverage to target volumes relative to traditional PBT methods while avoiding the increased RBE at the end of the beam. It has proven easy to design and implement and robust in our planning process. The method underscores the need to optimize treatment plans in PBT for both traditional energy dose in gray (Gy) and biologic dose (RBE).

KW - Bragg peak

KW - Patient safety

KW - Proton dosimetry

KW - Proton therapy

KW - Relative biological effectiveness (RBE)

KW - Toxicity

KW - Treatment planning

UR - http://www.scopus.com/inward/record.url?scp=84893191383&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84893191383&partnerID=8YFLogxK

U2 - 10.1186/1748-717X-9-2

DO - 10.1186/1748-717X-9-2

M3 - Article

C2 - 24383792

AN - SCOPUS:84893191383

VL - 9

JO - Radiation Oncology

JF - Radiation Oncology

SN - 1748-717X

IS - 1

M1 - 2

ER -